Search

everythinglearnresearchcommunity

for

Search:↓

A man with hair loss developed a condition causing scarring and inflammation in both bald and non-bald areas of his scalp.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

The Fas/FasL pathway may play a role in alopecia areata.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

FFA and FAPD might be related or stages of the same disease.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

The review found that specific changes in scalp tissue can help diagnose different types of hair loss.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Finasteride may lower cholesterol and slow heart disease progression.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Segmental vitiligo affects hair follicle melanocytes, causing small, uniform depigmented spots.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.